Earnings Feed
Start Free
Taysha Gene Therapies, Inc.·4

Jan 14, 4:45 PM ET

Nolan Sean P. 4

4 · Taysha Gene Therapies, Inc. · Filed Jan 14, 2026

Insider Transaction Report

Form 4
Period: 2026-01-12
Taysha Gene Therapies, Inc.TSHA
Nolan Sean P.
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-01-12+1,008,000→ 3,086,358 total
  • Award

    Employee Stock Option (right to buy)

    [F3]
    2026-01-12+648,000→ 648,000 total
    Exercise: $4.86Exp: 2036-01-12→ Common Stock (648,000 underlying)
Holdings

  • Common Stock

    [F2]
    (indirect: See footnote)
    1,535,545
Footnotes (3)
  • [F1]Represents a restricted stock unit ("RSU") award. The RSUs will vest in four equal annual installments beginning on January 12, 2027, subject to the Reporting Person's continuous service through each applicable vesting date.
  • [F2]The securities are held by Nolan Capital, LLC (the "LLC"). The Reporting Person is the President of the LLC and has shared voting and investment power with respect to the shares held by the LLC.
  • [F3]25% of the total number of shares underlying the option shall vest and become exercisable on January 12, 2027 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
Signature
/s/ Kamran Alam, Attorney-in-Fact|2026-01-14

Documents

1 file
  • 4
    form4-01142026_040103.xmlPrimary